DaVita Capex To Depreciation vs Price To Sales Ratio Analysis

DVA Stock

USD 163.74 2.43 1.46%

DaVita HealthCare financial indicator trend analysis is much more than just examining DaVita HealthCare latest accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether DaVita HealthCare is a good investment. Please check the relationship between DaVita HealthCare Capex To Depreciation and its Price To Sales Ratio accounts. Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in DaVita HealthCare Partners. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real.

Capex To Depreciation vs Price To Sales Ratio

Capex To Depreciation vs Price To Sales Ratio Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of DaVita HealthCare Capex To Depreciation account and Price To Sales Ratio. At this time, the significance of the direction appears to have significant contrarian relationship.

The correlation between DaVita HealthCare's Capex To Depreciation and Price To Sales Ratio is -0.21. Overlapping area represents the amount of variation of Capex To Depreciation that can explain the historical movement of Price To Sales Ratio in the same time period over historical financial statements of DaVita HealthCare Partners, assuming nothing else is changed. The correlation between historical values of DaVita HealthCare's Capex To Depreciation and Price To Sales Ratio is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Capex To Depreciation of DaVita HealthCare Partners are associated (or correlated) with its Price To Sales Ratio. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Price To Sales Ratio has no effect on the direction of Capex To Depreciation i.e., DaVita HealthCare's Capex To Depreciation and Price To Sales Ratio go up and down completely randomly.

Correlation Coefficient

-0.21

Relationship Direction	Negative
Relationship Strength	Insignificant

View All Relationships

Capex To Depreciation

The ratio of a company's capital expenditures to its depreciation expenses, indicating how much the company is investing in physical assets relative to the aging of existing assets.

Price To Sales Ratio

Price to Sales Ratio is figured by comparing DaVita HealthCare stock price to its revenues. An advantage to using Price to Sales ratio is that it is based on DaVita HealthCare sales, a figure that is much harder to manipulate than other DaVita HealthCare Partners multiples. Because sales tend to be more stable P/S ratio can be a good tool for screening cyclical companies fluctuating earnings patterns. A valuation ratio that compares a company's stock price to its revenues, calculated by dividing the company's market cap by its total sales or revenue over a 12-month period.

Most indicators from DaVita HealthCare's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into DaVita HealthCare current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in DaVita HealthCare Partners. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real.

At present, DaVita HealthCare's Discontinued Operations is projected to increase significantly based on the last few years of reporting. The current year's Tax Provision is expected to grow to about 235.8 M, whereas Selling General Administrative is forecasted to decline to about 797.4 M.

	2021	2022	2023	2024 (projected)
Gross Profit	3.6B	3.4B	3.8B	2.1B
Total Revenue	11.6B	11.6B	12.1B	7.1B

Gross Profit Total Revenue

DaVita HealthCare fundamental ratios Correlations

	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Property Plant And Equipment Net	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Non Currrent Assets Other	Cash And Short Term Investments	Net Receivables	Common Stock Shares Outstanding	Non Current Liabilities Total	Inventory	Other Current Assets	Other Stockholder Equity	Total Liab	Total Current Assets	Short Term Debt	Intangible Assets	Property Plant And Equipment Gross	Common Stock Total Equity	Common Stock
Total Assets		0.9	0.49	0.82	0.55	0.43	0.72	0.43	0.96	0.51	0.92	-0.52	0.49	0.93	0.46	0.91	0.8	0.49	0.67	0.95	0.67	0.32	0.32	0.19	0.46	0.45
Short Long Term Debt Total	0.9		0.57	0.73	0.13	0.72	0.86	0.01	0.86	0.27	0.89	-0.48	0.24	0.96	0.07	0.99	0.62	0.56	0.54	0.99	0.46	0.4	0.03	0.51	0.04	0.03
Other Current Liab	0.49	0.57		0.77	-0.06	0.62	0.75	-0.26	0.47	-0.28	0.27	-0.09	-0.28	0.57	-0.2	0.47	0.37	-0.12	0.46	0.58	0.65	0.78	-0.45	0.57	-0.1	-0.12
Total Current Liabilities	0.82	0.73	0.77		0.4	0.36	0.64	0.26	0.77	0.16	0.59	-0.42	0.13	0.78	0.27	0.66	0.57	0.05	0.62	0.8	0.84	0.76	0.0	0.17	0.31	0.3
Total Stockholder Equity	0.55	0.13	-0.06	0.4		-0.38	-0.02	0.94	0.53	0.69	0.39	-0.27	0.71	0.26	0.93	0.19	0.59	0.09	0.46	0.27	0.58	-0.1	0.72	-0.53	0.95	0.95
Property Plant And Equipment Net	0.43	0.72	0.62	0.36	-0.38		0.89	-0.54	0.4	-0.03	0.5	-0.14	-0.07	0.65	-0.37	0.68	0.27	0.44	0.28	0.64	0.09	0.37	-0.43	0.88	-0.35	-0.37
Net Debt	0.72	0.86	0.75	0.64	-0.02	0.89		-0.21	0.69	0.1	0.71	-0.19	0.06	0.83	-0.05	0.83	0.49	0.46	0.46	0.84	0.38	0.48	-0.14	0.78	-0.05	-0.06
Retained Earnings	0.43	0.01	-0.26	0.26	0.94	-0.54	-0.21		0.43	0.64	0.3	-0.28	0.66	0.16	0.95	0.09	0.5	0.04	0.18	0.15	0.46	-0.21	0.72	-0.67	0.86	0.87
Accounts Payable	0.96	0.86	0.47	0.77	0.53	0.4	0.69	0.43		0.47	0.89	-0.43	0.47	0.92	0.45	0.89	0.86	0.49	0.57	0.92	0.63	0.24	0.31	0.23	0.45	0.42
Cash	0.51	0.27	-0.28	0.16	0.69	-0.03	0.1	0.64	0.47		0.55	-0.33	0.98	0.34	0.7	0.35	0.56	0.45	0.38	0.34	0.18	-0.27	0.64	-0.22	0.74	0.74
Non Current Assets Total	0.92	0.89	0.27	0.59	0.39	0.5	0.71	0.3	0.89	0.55		-0.48	0.53	0.9	0.36	0.94	0.68	0.78	0.55	0.92	0.32	0.13	0.44	0.3	0.33	0.31
Non Currrent Assets Other	-0.52	-0.48	-0.09	-0.42	-0.27	-0.14	-0.19	-0.28	-0.43	-0.33	-0.48		-0.34	-0.52	-0.27	-0.46	-0.4	-0.28	-0.3	-0.51	-0.35	-0.12	-0.13	0.19	-0.2	-0.24
Cash And Short Term Investments	0.49	0.24	-0.28	0.13	0.71	-0.07	0.06	0.66	0.47	0.98	0.53	-0.34		0.32	0.69	0.32	0.61	0.45	0.38	0.3	0.17	-0.3	0.66	-0.24	0.76	0.76
Net Receivables	0.93	0.96	0.57	0.78	0.26	0.65	0.83	0.16	0.92	0.34	0.9	-0.52	0.32		0.22	0.96	0.73	0.52	0.51	0.98	0.54	0.4	0.06	0.43	0.19	0.17
Common Stock Shares Outstanding	0.46	0.07	-0.2	0.27	0.93	-0.37	-0.05	0.95	0.45	0.7	0.36	-0.27	0.69	0.22		0.14	0.47	0.12	0.21	0.2	0.44	-0.15	0.7	-0.53	0.9	0.91
Non Current Liabilities Total	0.91	0.99	0.47	0.66	0.19	0.68	0.83	0.09	0.89	0.35	0.94	-0.46	0.32	0.96	0.14		0.68	0.64	0.51	0.98	0.41	0.26	0.13	0.48	0.11	0.09
Inventory	0.8	0.62	0.37	0.57	0.59	0.27	0.49	0.5	0.86	0.56	0.68	-0.4	0.61	0.73	0.47	0.68		0.31	0.53	0.7	0.64	0.0	0.24	0.13	0.56	0.54
Other Current Assets	0.49	0.56	-0.12	0.05	0.09	0.44	0.46	0.04	0.49	0.45	0.78	-0.28	0.45	0.52	0.12	0.64	0.31		0.24	0.53	-0.29	-0.23	0.49	0.3	0.08	0.07
Other Stockholder Equity	0.67	0.54	0.46	0.62	0.46	0.28	0.46	0.18	0.57	0.38	0.55	-0.3	0.38	0.51	0.21	0.51	0.53	0.24		0.58	0.56	0.28	0.26	0.11	0.47	0.46
Total Liab	0.95	0.99	0.58	0.8	0.27	0.64	0.84	0.15	0.92	0.34	0.92	-0.51	0.3	0.98	0.2	0.98	0.7	0.53	0.58		0.56	0.41	0.11	0.42	0.18	0.16
Total Current Assets	0.67	0.46	0.65	0.84	0.58	0.09	0.38	0.46	0.63	0.18	0.32	-0.35	0.17	0.54	0.44	0.41	0.64	-0.29	0.56	0.56		0.51	-0.04	-0.1	0.48	0.48
Short Term Debt	0.32	0.4	0.78	0.76	-0.1	0.37	0.48	-0.21	0.24	-0.27	0.13	-0.12	-0.3	0.4	-0.15	0.26	0.0	-0.23	0.28	0.41	0.51		-0.37	0.3	-0.12	-0.12
Intangible Assets	0.32	0.03	-0.45	0.0	0.72	-0.43	-0.14	0.72	0.31	0.64	0.44	-0.13	0.66	0.06	0.7	0.13	0.24	0.49	0.26	0.11	-0.04	-0.37		-0.45	0.69	0.69
Property Plant And Equipment Gross	0.19	0.51	0.57	0.17	-0.53	0.88	0.78	-0.67	0.23	-0.22	0.3	0.19	-0.24	0.43	-0.53	0.48	0.13	0.3	0.11	0.42	-0.1	0.3	-0.45		-0.46	-0.49
Common Stock Total Equity	0.46	0.04	-0.1	0.31	0.95	-0.35	-0.05	0.86	0.45	0.74	0.33	-0.2	0.76	0.19	0.9	0.11	0.56	0.08	0.47	0.18	0.48	-0.12	0.69	-0.46		1.0
Common Stock	0.45	0.03	-0.12	0.3	0.95	-0.37	-0.06	0.87	0.42	0.74	0.31	-0.24	0.76	0.17	0.91	0.09	0.54	0.07	0.46	0.16	0.48	-0.12	0.69	-0.49	1.0

Click cells to compare fundamentals

DaVita HealthCare Account Relationship Matchups

DaVita HealthCare fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	17.3B	17.0B	17.1B	16.9B	16.9B	10.2B
Short Long Term Debt Total	11.2B	11.2B	12.0B	11.8B	11.1B	5.7B
Other Current Liab	756.2M	1.5B	1.4B	1.5B	1.6B	1.7B
Total Current Liabilities	2.4B	2.5B	2.4B	2.6B	2.6B	1.6B
Total Stockholder Equity	2.1B	1.4B	755.5M	712.3M	1.1B	1.9B
Property Plant And Equipment Net	6.3B	6.4B	6.3B	5.9B	5.6B	5.9B
Net Debt	10.1B	10.9B	11.5B	11.6B	10.7B	11.3B
Retained Earnings	1.4B	852.5M	354.3M	174.5M	598.3M	568.4M
Accounts Payable	403.8M	434.3M	402.0M	479.8M	514.5M	284.0M
Cash	1.1B	325.0M	461.9M	244.1M	380.1M	450.3M
Non Current Assets Total	13.6B	13.8B	14.0B	13.8B	13.8B	7.6B
Non Currrent Assets Other	(461.6M)	(730.1M)	(694.3M)	(467.2M)	271.3M	284.8M
Cash And Short Term Investments	1.1B	345.1M	484.2M	321.8M	391.7M	501.7M
Net Receivables	2.3B	2.4B	2.4B	2.6B	2.4B	1.4B
Common Stock Shares Outstanding	153.8M	122.6M	109.9M	95.8M	93.2M	149.6M
Liabilities And Stockholders Equity	17.3B	17.0B	17.1B	16.9B	16.9B	10.2B
Non Current Liabilities Total	11.4B	11.6B	12.4B	12.1B	12.2B	6.1B
Inventory	97.9M	111.6M	107.4M	109.1M	143.1M	83.8M
Other Current Assets	173.2M	253.2M	165.6M	173.7M	187.2M	104.4M
Other Stockholder Equity	749.0M	597.1M	540.3M	606.9M	509.8M	367.2M
Total Liab	13.8B	14.1B	14.8B	14.7B	14.2B	7.7B
Total Current Assets	3.7B	3.1B	3.2B	3.2B	3.1B	2.6B
Short Term Debt	474.6M	538.0M	573.4M	626.8M	517.7M	543.6M
Intangible Assets	135.7M	166.6M	177.7M	182.7M	203.2M	193.1M
Property Plant And Equipment Gross	6.3B	6.4B	11.1B	11.2B	11.3B	11.9B
Accumulated Other Comprehensive Income	(47.5M)	(66.2M)	(139.2M)	(69.2M)	(52.1M)	(54.7M)
Common Stock Total Equity	126K	110K	97K	90K	103.5K	149.1K
Common Stock	126K	110K	97K	90K	89K	147.1K
Other Liab	738.4M	959.7M	950.1M	888.0M	1.0B	1.1B
Other Assets	91.5M	79.5M	136.7M	1K	725.9M	762.2M
Long Term Debt	8.0B	7.9B	8.7B	8.7B	8.3B	6.2B
Property Plant Equipment	3.5B	3.5B	3.5B	3.3B	3.7B	2.0B
Good Will	6.8B	6.9B	7.0B	7.1B	7.1B	6.3B
Short Term Investments	11.6M	20.1M	22.3M	77.7M	11.6M	11.0M
Net Tangible Assets	(3.6B)	(4.4B)	(5.0B)	(5.2B)	(4.7B)	(4.9B)
Noncontrolling Interest In Consolidated Entity	185.8M	183.2M	180.6M	163.6M	147.2M	139.8M
Retained Earnings Total Equity	1.4B	852.5M	354.3M	174.5M	157.0M	149.2M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

TITAN	Titan Company Limited
U	Unity Software
PAYC	Paycom Soft

When determining whether DaVita HealthCare offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of DaVita HealthCare's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Davita Healthcare Partners Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Davita Healthcare Partners Stock:

How To Invest In DaVita

Details

Is DaVita Stock a good investment?

Details

What is DaVita HealthCare's Net Worth?

Details

Largest Health Care Providers & Services Companies

View

Largest Health Care Equipment & Services Companies

View

Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in DaVita HealthCare Partners. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real.

You can also try the Equity Valuation module to check real value of public entities based on technical and fundamental data.

Is Health Care Providers & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of DaVita HealthCare. If investors know DaVita will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about DaVita HealthCare listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Quarterly Earnings Growth

(0.05)

Earnings Share

9.27

Revenue Per Share

145.293

Quarterly Revenue Growth

0.046

Return On Assets

0.0694

The market value of DaVita HealthCare is measured differently than its book value, which is the value of DaVita that is recorded on the company's balance sheet. Investors also form their own opinion of DaVita HealthCare's value that differs from its market value or its book value, called intrinsic value, which is DaVita HealthCare's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because DaVita HealthCare's market value can be influenced by many factors that don't directly affect DaVita HealthCare's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between DaVita HealthCare's value and its price as these two are different measures arrived at by different means. Investors typically determine if DaVita HealthCare is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, DaVita HealthCare's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

DaVita Capex To Depreciation vs Price To Sales Ratio Analysis

Capex To Depreciation vs Price To Sales Ratio

Capex To Depreciation vs Price To Sales Ratio Correlation Analysis

Correlation Coefficient

Capex To Depreciation

Price To Sales Ratio

DaVita HealthCare fundamental ratios Correlations

DaVita HealthCare Account Relationship Matchups

High Positive Relationship

High Negative Relationship

DaVita HealthCare fundamental ratios Accounts

Also Currently Popular

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Common Stock	+ 1.0	Common Stock Total Equity
Non Current Liabilities Total	+ 0.99	Short Long Term Debt Total
Total Liab	+ 0.99	Short Long Term Debt Total
Cash And Short Term Investments	+ 0.98	Cash
Total Liab	+ 0.98	Net Receivables
Total Liab	+ 0.98	Non Current Liabilities Total

Property Plant And Equipment Gross	- 0.67	Retained Earnings
Retained Earnings	- 0.54	Property Plant And Equipment Net
Property Plant And Equipment Gross	- 0.53	Common Stock Shares Outstanding
Property Plant And Equipment Gross	- 0.53	Total Stockholder Equity
Net Receivables	- 0.52	Non Currrent Assets Other
Non Currrent Assets Other	- 0.52	Total Assets